Jayson Bedford
Stock Analyst at Raymond James
(4.68)
# 811
Out of 5,058 analysts
734
Total ratings
59.6%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Reiterated: Buy | $48 → $53 | $35.14 | +50.83% | 9 | Sep 25, 2026 | |
| MDT Medtronic | Reiterated: Hold | n/a | $94.23 | - | 30 | Sep 2, 2026 | |
| ICUI ICU Medical | Reiterated: Buy | $180 → $200 | $162.69 | +22.93% | 60 | Aug 7, 2026 | |
| TFX Teleflex | Reiterated: Buy | $150 → $155 | $123.29 | +25.72% | 14 | Aug 7, 2026 | |
| DXCM DexCom | Reiterated: Buy | $91 → $94 | $83.47 | +12.62% | 76 | Jul 31, 2026 | |
| MMSI Merit Medical Systems | Reiterated: Buy | $83 → $100 | $87.16 | +14.73% | 46 | Jul 31, 2026 | |
| SYK Stryker | Reiterated: Buy | $418 → $370 | $281.62 | +31.38% | 5 | Jul 31, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | n/a | $102.97 | - | 85 | Jul 17, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $603 → $483 | $420.24 | +14.93% | 16 | Jul 17, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $209 → $265 | $253.91 | +4.37% | 69 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $263 → $216 | $133.93 | +61.28% | 46 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $124 → $88 | $43.00 | +104.65% | 76 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $91.77 | - | 9 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $96 | $86.45 | +11.05% | 30 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $26.37 | -27.95% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $8.10 | n/a | 26 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $24.80 | n/a | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.18 | n/a | 29 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $188.89 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.51 | n/a | 16 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.01 | n/a | 17 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $13 | $11.05 | n/a | 41 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 12 | Jul 23, 2019 |
Axogen
Sep 25, 2026
Reiterated: Buy
Price Target: $48 → $53
Current: $35.14
Upside: +50.83%
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: n/a
Current: $94.23
Upside: -
ICU Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $180 → $200
Current: $162.69
Upside: +22.93%
Teleflex
Aug 7, 2026
Reiterated: Buy
Price Target: $150 → $155
Current: $123.29
Upside: +25.72%
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $91 → $94
Current: $83.47
Upside: +12.62%
Merit Medical Systems
Jul 31, 2026
Reiterated: Buy
Price Target: $83 → $100
Current: $87.16
Upside: +14.73%
Stryker
Jul 31, 2026
Reiterated: Buy
Price Target: $418 → $370
Current: $281.62
Upside: +31.38%
Abbott Laboratories
Jul 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $102.97
Upside: -
Intuitive Surgical
Jul 17, 2026
Reiterated: Buy
Price Target: $603 → $483
Current: $420.24
Upside: +14.93%
Johnson & Johnson
Jul 16, 2026
Reiterated: Buy
Price Target: $209 → $265
Current: $253.91
Upside: +4.37%
Jun 8, 2026
Reiterated: Buy
Price Target: $263 → $216
Current: $133.93
Upside: +61.28%
Mar 27, 2026
Reiterated: Buy
Price Target: $124 → $88
Current: $43.00
Upside: +104.65%
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $91.77
Upside: -
Nov 3, 2025
Upgraded: Buy
Price Target: $96
Current: $86.45
Upside: +11.05%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $26.37
Upside: -27.95%
Aug 8, 2025
Reiterated: Sell
Price Target: n/a
Current: $8.10
Upside: n/a
Aug 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $24.80
Upside: n/a
Aug 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $13.18
Upside: n/a
May 2, 2025
Downgraded: Hold
Price Target: n/a
Current: $188.89
Upside: n/a
Nov 16, 2023
Downgraded: Hold
Price Target: n/a
Current: $11.51
Upside: n/a
May 4, 2023
Reiterated: Hold
Price Target: n/a
Current: $16.01
Upside: n/a
Apr 17, 2023
Reiterated: Buy
Price Target: $14 → $13
Current: $11.05
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a